We are live on ! Find out more
TENX icon

Tenax Therapeutics

21 hedge funds and large institutions have $4.25M invested in Tenax Therapeutics in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

25,168% more capital inflows, than outflows

Capital inflows: $4.4M | Capital outflows: $17.4K

250% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 4

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

91% more funds holding

Funds holding: 11 → 21 (+10)

35.08% more ownership

Funds ownership: 0.96% → 36.04% (+35%)

Holders
21
Holders Change
+10
Holders Change %
+90.91%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
3
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

TENX Hedge Fund Activity: Q3 2024 in Review

21 of the 6,989 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q3 2024, worth a combined $4.25M — up 7,334% from $57.2K a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new TENX positions and 4 closed out — a net gain of 10 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was BVF Inc, opening a new position worth an estimated $1.23M. The largest seller was Qube Research & Technologies (QRT), exiting entirely with an estimated $13.4K sold.

  • 21 institutional investors held Tenax Therapeutics (TENX) as of Q3 2024, up from 11 in Q2 2024.
  • Funds reported $4.25M of Tenax Therapeutics stock for Q3 2024, up 7,334% quarter-over-quarter.
  • 14 funds opened new Tenax Therapeutics positions in Q3 2024 and 4 closed out, a net change of +10 holders.
  • The largest Tenax Therapeutics buyer in Q3 2024 was BVF Inc, an estimated $1.23M added.
  • The largest Tenax Therapeutics seller in Q3 2024 was Qube Research & Technologies (QRT), an estimated $13.4K sold.

Based on aggregated 13F filings for Q3 2024.